Clinical Trials Browser

Completed × INDUSTRY × crenolanib × Clear all

NCT02626338 2023-12-20

Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML

Phase 1/2 Completed

16 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00949624 2012-01-19

CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors